Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

It might--a 10 million dollars a day drug and reasonably good odds of a positive outcome (of course this is debatable and uncertain) on remand. Even the Solicitor General was of the opinion that if "clear error" standard was applied on remand, the case would still come out in favor of MNTA/Sandoz. A risk for sure but with a potential big return if FDA approved today. Regards, bp